Health conditions
GLP-1s, pregnancy and breastfeeding
October 2, 2026 · 6 min read · Medically reviewed by Bryan Milton, MD · Reviewed October 2, 2026
These medications are not for use in pregnancy. What the labels say about stopping before conceiving, why lead time matters, and what to do if you are pregnant.
This is the clearest answer in this cluster: GLP-1 medications are not for use in pregnancy. If you are pregnant, planning a pregnancy, or breastfeeding, that changes whether treatment is appropriate, and it is something to raise before starting rather than after.
What the labels say
The approved products for chronic weight management carry a clear position: weight loss offers no benefit during pregnancy and may cause fetal harm, so they are not for use in pregnancy and should be discontinued when pregnancy is recognised. The labels also address stopping in advance of a planned pregnancy, with a washout period reflecting how long the medication persists in the body.
That washout is the reason this is a planning question. These medications are built to last long enough for weekly dosing, so they do not clear immediately — the lead time before conceiving is measured in weeks, not days. Your own label and your clinician give the specific period for your medication.
If you are planning a pregnancy
- Raise it early, before you start trying. The stopping timeline needs planning around.
- Ask about the washout period for your specific medication.
- Discuss what to do in the interim, including whether weight-related care should continue by other means.
- Ask about folate and general preconception care, which belongs in this conversation anyway.
- Do not simply stop and start trying in the same month without asking.
If you become pregnant while taking one
Contact your clinician promptly — that day rather than at your next scheduled check-in. Do not panic: the medication is discontinued when pregnancy is recognised, which is what the labels direct, and the conversation then moves to appropriate prenatal care. What matters is that someone clinical knows now.
| Situation | What to do |
|---|---|
| Pregnant now | Contact your clinician promptly; treatment is discontinued |
| Planning a pregnancy | Discuss the washout period and stop in advance, per your label |
| Might become pregnant | Discuss contraception, and see the birth control article |
| Breastfeeding | Raise it — the labels address lactation and advise against use |
| Unsure if pregnant | Test, and contact your clinician; do not continue dosing on an assumption |
Breastfeeding
The approved labels advise against use while breastfeeding, reflecting the absence of data on the presence of these medications in human milk and their effects on a breastfed infant. If you are breastfeeding or planning to, raise it before starting; your clinician can discuss alternatives and timing.
Contraception while on treatment
Because these medications are not for use in pregnancy, contraception is part of the clinical picture rather than a side issue. The tirzepatide labels in particular advise extra precautions for people using oral contraceptives around starting treatment and after each dose increase, because delayed gastric emptying can affect absorption. That is covered in detail in the birth control article.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. All of the above applies to compounded preparations, and GLP's clinicians screen for pregnancy status and plans as part of the assessment.
This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.